Frank W Marcoux

Title: Frank W. Marcoux: Innovator in Biologically Active Peptides

Introduction

Frank W. Marcoux is a notable inventor based in Stonington, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of human-derived cell-permeable peptides. With a total of 2 patents, his work focuses on innovative methods for delivering biologically active molecules into cells.

Latest Patents

Marcoux's latest patents include groundbreaking compositions for conjugates, including fusion proteins. These inventions provide methods for treating a variety of conditions by utilizing a 60-amino acid human homeodomain. This technology allows for the translocation of functional and regulatory peptides, proteins, and other biologically active molecules across cell and nuclear membranes. Importantly, these conjugates can pass through the blood-brain barrier, facilitating entry into the central nervous system (CNS). The disclosed compositions are designed for the delivery of gene expression products and novel peptides or polynucleotides to regulate gene function.

Career Highlights

Frank W. Marcoux is currently associated with Portage Pharmaceuticals Ltd., where he continues to advance his research and innovations. His work has the potential to revolutionize treatments for various medical conditions by improving the delivery mechanisms of therapeutic agents.

Collaborations

Throughout his career, Marcoux has collaborated with esteemed colleagues, including Bruce H. Littman and John F. Thompson. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Frank W. Marcoux stands out as a pioneering inventor in the field of biotechnology, with a focus on enhancing the delivery of biologically active peptides. His contributions are poised to make a significant impact on medical treatments and therapies in the future.